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ABSTRACT Mammalian cells express two distinct forms
of transcription factor CREB (cAMP response element binding
protein) that are apparently the products of alternative splicing
of the CREB gene transcript. The two proteins differ by a
14-amino acid serine-rich insertion present in one of the CREB
isoforms. We show that both CREB isoforms are expressed in
many cell types and mammalian species. Both encode proteins
that bind specifically to a cAMP response element in vitro. As
expected for proteins of this class, the CREB proteins bind
DNA as dimers. Both proteins impart cAMP-regulated tran-
scriptional activity to a heterologous DNA-binding domain,
showing that cAMP directly modulates the transcriptional
stimulatory activity of CREB. The presence of multiple CREB
isoforms with identical DNA-binding specificities but differ-
ences in the presumed regulatory domain raises the possibility
that CREB proteins may be able to integrate distinct regulatory
signals at the level of gene transcription.
cAMP is an example of a "second messenger" that relays
extracellular signals to intracellular targets. Elevation of
intracellular cAMP concentrations leads to activation of
cAMP-dependent protein kinase (PKA) and subsequently to
changes in the pattern of cellular gene transcription (1).
Activation of PKA is both necessary and sufficient for the
transcriptional response to cAMP (2-5).
Most genes induced by cAMP share a conserved DNA
sequence that constitutes a cAMP-responsive element (CRE)
(for review, see ref. 6). Mammalian cells contain multiple
proteins that bind this sequence (see, for example, refs.
7-12). One ofthese proteins, CREB (cAMP response element
binding protein) (7, 8), is a 43-kDa phosphoprotein that is a
substrate for PKA in vitro (8). Mutation of the serine residue
phosphorylated by PKA prevents activation of CREB by
PKA in vitro (13). Two cDNAs encoding CREB have re-
cently been isolated-one from a human placenta library (11)
and a second from a rat brain library (12). The two clones
encode highly related proteins that differ primarily by a
14-amino acid region found only in the rat clone. This
difference could be due to species or tissue specificity, and its
functional significance is not known. We report here on the
isolation of CREB cDNA clones from a human T-cell cDNA
library.t We establish that both CREB isoforms are ex-
pressed ubiquitously and describe the properties of the
proteins encoded by the two cDNAs.
MATERIALS AND METHODS
cDNA Isolation. CREB cDNAs were amplified by poly-
merase chain reaction from a human peripheral blood T-cell
cDNA library in AgtlO (ref. 14; extracted phage DNA kindly
provided by C. Nicolet, Cold Spring Harbor Laboratory),
using two oligonucleotides that carried sequence comple-
mentary to the first and last 20 nucleotides ofthe CREB open
reading frame, respectively (11). Amplification reaction mix-
tures (100 p1L) contained 70 ng of library DNA, 100 pmol of
each phosphorylated oligonucleotide, and 2.5 units of Ther-
mus aquaticus DNA polymerase (Taq polymerase) (Perkin-
Elmer/Cetus). The amplification cycle was 1 min at 940C, 1
min at 65TC, 5 min at 740C, and it was repeated for a total of
35 cycles. The 1-kilobase CREB cDNA fragment was the
major product of the reaction. The CREB cDNA fragment
was cloned in pBSM13+ (Stratagene). Eight independent
clones carrying CREB inserts were fully sequenced by using
a set of oligonucleotide primers based on a published CREB
sequence (11). All eight clones were fully sequenced on one
strand, while one clone ofeach class was also fully sequenced
on the opposite strand.
Other Constructions. To construct the probe plasmid for
RNase protection assays of CREB mRNA, a 176-base-pair
(bp) Hae III fragment of the CREB-B cDNA was cloned into
the HincIl site of pBSM13 +.
Mutagenesis of the c-fos promoter to convert its natural
CRE to a GAL4 binding site was performed by site-directed
mutagenesis (15). The parental plasmid was a c-fos-
chloramphenicol acetyltransferase fusion plasmid carrying
c-fos sequences from -71 to +109 and six tandem repeats of
a synthetic simian virus 40 enhancer element (16). The GAL4
sequence used (see Fig. 5) was based on Webster et al. (17).
To construct the GAL4-CREB fusion protein expression
plasmids, we placed the entire CREB open reading frame
downstream of the yeast GAL4 DNA-binding domain
[GAL4, 1-147; originally derived from the plasmid pMA424
(18)]. The fusion protein was expressed under the control of
the cytomegalovirus promoter and 5'-untranslated sequences
from the herpes simplex virus thymidine kinase gene. The
structure of this plasmid is shown in Fig. 5; details of this
construction are available upon request.
RNA Analysis. Methods for transient expression assays
and RNA analysis have been described (16). RNA from
mouse tissues was a gift from M. Steinhelper, L. Field, and
J. Skowronski (Cold Spring Harbor Laboratory).
In Vito Translation Assays. Templates for in vitro tran-
scription of CREB cDNAs were prepared by polymerase
chain reaction amplification of single-stranded phagemid
DNA. Amplification yielded a double-stranded fragment
carrying the CREB cDNA linked to adjacent bacteriophage
promoters. For preparing truncated CREB proteins, we
prepared oligonucleotides that hybridized to CREB DNA at
the desired locations (see Fig. 4) and carried at the 5' end a
T7 RNA polymerase promoter. These were used as primers
Abbreviations: PKA, cAMP-dependent protein kinase A; CRE,
cAMP response element; CREB, cAMP response element binding
protein; IBMX, isobutylmethylxanthine.
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GenBank data base (accession no. M34356).
5258
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Natl. Acad. Sci. USA 87 (1990) 5259
in polymerase chain reactions in conjunction with a primer
that hybridized to the 3' end of the CREB coding sequence.
Approximately 1 ,ug of each amplified fragment was tran-
scribed in vitro with T7 RNA polymerase. The resulting
RNAs were translated in vitro by using a rabbit reticulocyte
lysate (Promega) in the presence of [35S]methionine. Mobil-
ity-shift assays were carried out as described (16).
RESULTS
Two DistinctCREB cDNAs. To study the role ofCREB in the
control of c-fos transcription of cAMP (16), we wished to
obtain a full-length CREB cDNA. We designed oligonucleo-
tides corresponding to the first seven and last seven codons of
the human CREB sequence obtained by Hoeffler et al. (11) and
used these oligonucleotides in a polymerase chain reaction to
amplify CREB cDNAs from a human peripheral blood T-cell
cDNA. The amplified DNA was cloned into a plasmid vector
and eight isolates were completely sequenced. The eight
clones fell into two distinct groups that differed by a 42-bp
insertion present in three of the eight clones. In addition, we
noted 13 nucleotide substitutions that were unique to individ-
ual clones, which we presume are due to misincorporation by
Taq polymerase during amplification. Because each substitu-
tion was found in only a single isolate, consensus nucleotides
at each position were easily established.
Fig. 1 shows the consensus nucleotide sequences ofthe two
CREB cDNAs. The cDNA termed CREB-A was identical in
sequence to that reported by Hoeffler et al. (11) except for a
region spanning amino acids 57-64, where our sequence
showed five substitutions and one inserted amino acid relative
to the reported sequence. In each case, the amino acids
encoded at these positions in our clones matched those found
in the rat clone (12). The second cDNA, termed CREB-B,
contained a 42-bp insertion, encoding 14 additional amino
acids beginning at amino acid 88 and resuming CREB-A
sequence at amino acid 102. This precise 14-amino acid stretch
is found in an identical position in the rat cDNA. Except for
this insertion, the two human cDNAs were identical in nucle-
otide sequence. Thus, two distinct forms of human CREB are
apparently encoded by alternate transcripts of a single gene.
The discrepancy between the two previously reported se-
quences (11, 12) is not due to species differences.
Both CREB mRNAs Are Ubiquitously Expressed. To study
the pattern of expression of the two CREB mRNAs, we
prepared an RNase protection probe that spanned the CREB-
B insert. CREB-B mRNA can hybridize contiguously to the
probe, leading to protection of the entire CREB sequence in
the probe. Hybridization to CREB-A mRNA loops out the
insert region of the probe, which is cleaved by RNase T1 to
generate two smaller probe fragments, only the larger ofwhich
is seen in the figures. Thus, probe fragments protected by the
two mRNAs were easily resolved by gel electrophoresis. Fig.
2A shows that both mRNAs were observed in several human
cell lines, including H9 and Jurkat T lymphoblasts, WI-38
fibroblasts, HeLa, and HepG2 hepatoma cells. In addition, full
protection of identical probe fragments was observed in RNA
samples from several rodent cell lines, including rat 208F
fibroblasts, BALB/c 3T3 fibroblasts, and mouse F9 embryo-
nal carcinoma stem cells and differentiated cultures. Thus,
both CREB mRNAs were expressed simultaneously in all
these cell lines. In general, CREB-A mRNA was expressed at
severalfold higher levels than CREB-B mRNA.
Because we could obtain protection of the full human
CREB probe with mouse RNA, we also surveyed a variety of
mouse tissues. Again, both CREB mRNAs were expressed in
all tissues examined, with CREB-A mRNA being more
abundant (Fig. 2B). CREB-B mRNA appeared to be espe-
cially abundant in brain. The main conclusion from this
analysis is that both CREB mRNAs are widely expressed and
that there is no striking tissue specificity to their expression.
Both cDNAs Encode Proteins That Bind a CRE in Vitro. To
determine whether both cDNAs encode CREBs, we tran-
scribed both cDNAs into mRNA with T7 RNA polymerase
and translated the mRNAs in a rabbit reticulocyte lysate. Fig.
3A shows that both mRNAs encode proteins with apparent
molecular masses of -45 kDa, consistent with the reported
size of the purified rat protein (7). Fig. 3B shows a mobility-
shift assay of the proteins translated in vitro. The probe
carries a CRE from the mouse c-fos promoter (16). Transla-
tion products from both mRNAs yield strong CRE binding
activities not detectable in control lysates (compare lanes 2-7
with lanes 8-10). These complexes closely comigrated with
the major complex observed with nuclear extracts from H9 T
lymphoblasts (lane 1). The complexes are sequence specific,
because they did not form with a similar probe carrying four
nucleotide substitutions that inactivate the CRE (16) (lanes 11
and 12). Thus, both CREB mRNAs encode proteins that are
functional in DNA-binding assays in vitro.
CREB belongs to the "leucine zipper" family of DNA-
binding proteins (for review, see ref. 19). These proteins bind
to DNA as dimers, and DNA binding requires a region rich
1 M T M e S G A E N Q 0 S G D A A V T E A E N 0 Q M T V Q A Q P Q I A T L A Q V S
1 ATG ACC ATGG C GAG AAC CAG CAG AGT GGA GAT GCA GCT GTA ACA GAA GCT GAA AAC CAA CAA ATG ACA GTT CAA GCC CAG CCA CAG ATT GCC ACA TTA GCC CAG GTA TCT
41 H P A A H A T S S A P T V T L V 0 L P N G 0 T V Q V H G V I Q A A Q P S V I Q S
121 ATG CCA GCA GCT CAT GCA ACA TCA TCT GCT CCC ACC GTA ACT CTA GTA CAG CTG CCC AAT GGG CAG ACA GTT CAA GTC CAT GGA GTC ATT CAG GCG GCC CAG CCA TCA GTT ATT CAG TCT
81 P 0 V Q T V Q S S C K D L K R L F S G T 01 I S T I A E S E D S 0 E S V D S V T D
241 CCA CAA GTC CAA ACA GTT CAG TCT TCC TGT AAG GAC TTA AAA AGA CTT TTC TCC GGA ACA CAG |ATT TCA ACT ATT GCA GAA AGT GAA GAT TCA CAG GAG TCA GTG GAT AGT GTA ACT GAT
121 S 0 K R R E I L S R R P S Y R K I L N D L S S D A P G V P R I E E E K S E E E T
361 TCC CAA AAG CGA AGG GAA ATT CTT TCA AGG AGG CCT TCC TAC AGG AAA ATT TTG AAT GAC TTA TCT TCT GAT GCA CCA GGA GTG CCA AGG ATT GAA GAA GAG AAG TCT GAA GAG GAG ACT
161 S A P A I T T V T V P T P I Y 0 T S S G Q Y I A I T 0 G G A I 0 L A N N G T D G
481 TCA GCA CCT GCC ATC ACC ACT GTA ACG GTG CCA ACT CCA ATT TAC CAA ACT AGC AGT GGA CAG TAT ATT GCC ATT ACC CAG GGA GGA GCA ATA CAG CTG GCT AAC AAT GGT ACC GAT GGG
201 V Q G L Q T L T M T N A A A T Q P G T T I L Q Y A 0 T T D G 0 0 I L V P S N 0 V
601 GTA CAG GGC CTG CAA ACA TTA ACC ATG ACC AAT GCA GCA GCC ACT CAG CCG GGT ACT ACC ATT CTA CAG TAT GCA CAG ACC ACT GAT GGA CAG CAG ATC TTA GTG CCC AGC AAC CAA GTT
241 V V 0 A A S G D V 0 T Y 0 I R T A P T S T I A P G V V M A S S P A L P T Q P A E
721 GTT GTT CAA GCT GCC TCT GGA GAC GTA CAA ACA TAC CAG ATT CGC ACA GCA CCC ACT AGC ACT ATT GCC CCT GGA GTT GTT ATG GCA TCC TCC CCA GCA CTT CCT ACA CAG CCT GCT GAA
281 E A A R K R E V R L M K N R E A A R E C R R K K K E Y V K C L E N R V A V L E N
841 GAA GCA GCA CGA AAG AGA GAG GTC CGT CTA ATG AAG AAC AGG GAA GCA GCT CGA GAG TGT CGT AGA AAG AAG AAA GAA TAT GTG AAA TGT TTA GAA AAC AGA GTG GCA GTG CTT GAA AAT
321 0 N K T L I E E L K A L K D L Y C H K S D
961 CAA AAC AAG ACA TTG ATT GAG GAG CTA AAA GCA CTT AAG GAC CTT TAC TGC CAC AA TCA GA TAA
FIG. 1. Sequence of CREB cDNA clones. The sequence shown represents the consensus nucleotides at each position in eight independently
isolated clones (see text). The underlined sequences at the 5' and 3' ends were encoded in the oligonucleotide primers and therefore were not
independently determined. The boxed region indicates sequence present only in the CREB-B cDNA.
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FIG. 2. In vivo expression pattern of CREB mRNAs. (A) RNase protection analysis of CREB mRNAs from human and rodent cell lines (10
,ug of total cytoplasmic RNA was assayed in each lane). Lanes: 1, HeLa human epithelioid carcinoma; 2, H9 human T lymphoblast; 3, HepG2
human hepatoma; 4, WI-38 human fetal fibroblast; 5, Jurkat human T lymphoblast; 6, 208F rat fibroblast; 7, C6 rat glioma; 8, F9 mouse embryonal
carcinoma; 9, F9 culture treated with retinoic acid to induce differentiation; 10-12, quiescent BALB/c 3T3 mouse fibroblasts (lane 10) treated
for 60 min with 10% calf serum (lane 11) or IBMX and forskolin (lane 12). The probe fragments protected by CREB-A (A) and CREB-B (B)
mRNAs are indicated on the right. (B) RNase protection analysis of CREB mRNAs in mouse tissues. The tissues examined are shown above
the gel (lanes 1-11); 10 ,ug of RNA was assayed. Lanes 12-15, control hybridizations performed with in vitro-transcribed CREB-A and CREB-B
mRNAs. Each panel is derived from a single gel from which empty space was removed to conserve space.
in basic amino acids N terminal to the leucine zipper. To
determine whether CREB proteins behaved similarly, we
prepared a series of N-terminal truncations by in vitro
transcription and translation of polymerase chain reaction-
amplified templates. Fig. 4 shows the mobility-shift com-
plexes obtained with full-length CREB-A (lane 2) and CREB-
B (lane 11) proteins. Lanes 3-6 show the complexes obtained
with N-terminally truncated CREB-B proteins. A truncation
beginning at the insert had no detectable DNA-binding ac-
tivity (lane 3), although significant levels of the 256-amino
acid protein were synthesized (data not shown). Whether this
represents a specific regulatory effect of the insert or a
nonspecific folding problem is not yet clear. A shorter protein
carrying the C-terminal 202 amino acids was fully active,
yielding a faster migrating complex (lane 4). A 69-residue
protein beginning just N terminal to the basic region retained
specific DNA-binding activity (lane 6). A protein lacking the
basic region but retaining the leucine zipper (45 amino acids)
was not active for DNA binding (lane 6). To determine
whether the CREB proteins formed dimers, we cotranslated
full-length CREB-A mRNA with truncated CREB-B
mRNAs. In two cases, complexes of intermediate mobility
were observed (lanes 8 and 10, arrows), showing that the
active binding species is a dimer. When CREB-A mRNA was
A
cotranslated with the two CREB-B truncations that were not
active as homodimers, no heterodimeric protein-DNA com-
plexes were observed (lanes 7 and 10). However, in the case
of the 256-amino acid CREB-B truncation, the yield of
CREB-A homodimer complex was substantially reduced,
suggesting that the truncated CREB-B protein may still be
competent for dimerization, yielding heterodimers with no
DNA-binding activity. Thus, these experiments show that
CREB binds DNA as a dimer. They further suggest that
CREB-A:CREB-B heterodimers may form, but we have not
demonstrated this directly with full-length proteins. Similar
studies were recently reported by Dwarki et al. (26).
Both CREB mRNAs Encode Proteins That Impart cAMP-
Responsiveness to a Heterologous DNA-Binding Domain in
Vivo. In vivo assay of the activities of these proteins encoded
by these cDNAs is complicated by the presence ofCREB and
related activities in all of the cell lines we examined. More-
over, we wished to separate cAMP effects on CREB tran-
scriptional activity from any possible effects on DNA bind-
ing. Therefore, we reprogrammed the DNA-binding speci-
ficity of the CREB proteins by fusing the DNA-binding
domain of the yeast transcriptional activator GAL4 (18) to the
N terminus of the CREB proteins. The fusion proteins
contained the first 147 amino acids of the GAL4 protein,
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FIG. 3. In vitro translation of CREB proteins. (A)
SDS/PAGE analysis of in vitro translated proteins.
Lane 1, molecular mass markers (kDa); lanes 2 and 3,
1 and 5 p.l of translation lysate programmed by CREB-
A mRNA; lanes 4 and 5, 1 and 5 ul of translation lysate
programmed by CREB-B mRNA. (B) Mobility-shift
assay of in vitro translated CREB proteins. The probe
was a 50-bp restriction fragment carrying the wild-type
c-fos CRE (lanes 1-10 and 14) or an inactive mutant
(pm3; lanes 11-13) (18). Lanes: 1 and 13, H9 T-
lymphoblast cell extract; 2-4, and 11, the indicated
volumes (in 1l) of translation lysate programmed by
CREB-A mRNA; 5-7, and 12, the indicated volumes
(in 1A) of translation lysate programmed by CREB-B
mRNA; 8-10, the indicated volumes (in pA1) of trans-
lation lysate programmed by brome mosaic virus
mRNA.
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respond to a transcription factor bound there. When cotrans-
fected with plasmids expressing either of the full-length
GAL4-CREB fusion proteins, the substituted c-fos promoter
became strongly cAMP-responsive (lanes 7-10). Thus, the
presence of these fusion proteins converted the GAL4 bind-
ing site into a CRE. To show that this effect required the
expression of fusion proteins in trans, we prepared a small
insertion by filling in a BstXI site near the 5' end of the CREB
cDNA, shifting the reading frame. This plasmid carries all of
the DNA sequence present in the active plasmid, but it
-71wt -71 pm50 -71 pm3
GAL4 GC-A GC-B GMfs GC-A
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FIG. 4. Mobility-shift assay of truncated CREBs. The drawings
represent the N-terminally truncated CREB-B prepared by in vitro
translation. Solid box indicates the insert unique to CREB-B; open
box represents the basic region; stippled box represents the leucine
zipper. Lanes: 1, H9 cell extract; 2, full-length CREB-A; 3-6, the
indicated truncated CREB-B; 7-10, cotranslated CREB-A and
CREB-B derivatives; 11, full-length CREB-B; 12, unprogrammed
translation lysate. Arrows point to complexes in cotranslations (lanes
8 and 9) with mobilities intermediate between those obtained with the
two proteins translated individually; these complexes represent
binding by heterodimers of full-length CREB-A and truncated
CREB-B.
followed by 7 linker amino acids that included several po-
tential helix breakers, and then the entire CREB proteins,
including the DNA-binding domain and leucine zipper. To
assay the transcriptional activities of these proteins in vivo,
we used site-directed mutagenesis to convert the CRE in a
c-fos promoter derivative to a GAL4 binding site (Fig. 5). We
transfected this test plasmid into BALB/c 3T3 cells together
with plasmids that expressed the GAL4-CREB fusion pro-
teins from a viral promoter. Also included in the transfections
was a plasmid encoding the human a-globin gene, which
served as an internal control for transfection efficiency and
RNA recovery. The transfected cells were starved for serum
for 48 hr and subsequently treated for 1 hr with isobutyl-
methylxanthine (IBMX) (a phosphodiesterase inhibitor) and
forskolin (an activator of adenylate cyclase). Total cytoplas-
mic RNA was harvested and assayed for correctly initiated
c-fos and globin transcripts by RNase protection.
Fig. 5 shows that whereas the wild-type A-71 c-fos pro-
moter was strongly induced by IBMX and forskolin (lanes 1
and 2), the construct in which the c-fos CRE was substituted
with a GAL4 site was not [lanes 3 and 4; the small induction
seen in this and other control lanes is likely due to the
influence of CRE-like sequences present in vector DNA
upstream of the c-fos promoter (16)]. When this substituted
c-fos promoter was cotransfected with a plasmid expressing
full-length yeast GAL4 protein, its activity was augmented in
the presence and absence of stimuli (lanes 5 and 6), showing
that the promoter carries an active GAL4 binding site and can
_m M a d -M~ -M- --M --_ _
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Expressor Plasmids
... ATG GCT TCT AGG ATG ... ... CCG GAA TTT CCG GGG TOT AGA ATG ...
CMV HSVtk5'-UT GAL41-147 CREBcDNA
Indicator Plasmids
-71 +109
c-FOS CAT
-71 Wt -71 CCAGTQACGTAGGAAGTCCATC -50
-71 pm3 -71 CCACTCACCTAGGAAGTCCATC -50
-71 pm5O --1 CGGAGTCACTrGTrCCTCCGCCATC -50
FIG. 5. Functional assay of CREBs in vivo. Indicated combina-
tions of indicator and expresser plasmids were transiently trans-
fected into duplicate cultures of BALB/c 3T3 cells. Transfections
contained 10 ,ug of indicator plasmid, 100 ng of expressor plasmid,
and 2 tug of a-globin internal control plasmid. Two days after
transfection, one culture from each pair was treated with IBMX and
forskolin (lanes +). Indicator plasmids carried either a wild-type
CRE (lanes 1 and 2), an inactive mutant CRE (lanes 13 and 14), or
a GAL4 binding site in place of the CRE (lanes 3-12). Expressor
plasmids expressed full-length yeast GAL4 protein (lanes 5 and 6).
GAL4-GREB-A fusion (lanes 7, 8, 13, and 14), GAL4-CREB-B
fusion (lanes 9 and 10), GAL4-CREB-B with a frameshift mutation
(lanes 11 and 12). Equal amounts ofRNA from transfected cells were
assayed by RNase protection as described (18, 20). Half of the
hybridization reactions were analyzed to verify that endogenous
c-fos induction was equivalent in all samples. Subsequently, the
remaining portions of the hybridization were run on a second gel
(shown here) with the amounts adjusted to equalize the signals from
the internal control. T, E, and a indicate the probe fragments
protected by transcripts of the transfected indicator plasmid, endog-
enous c-fos, and a-globin internal control plasmid, respectively.
Shown below are schematic representations of the expressor and
indicator plasmids. For the expressor plasmids, junction sequences
between segments are shown; underlined nucleotides are the first and
last codons in each unit. In the promoter sequences of the indicator
plasmids, dots above each sequence mark positions where each
plasmid differs from wild type. CMV, cytomegalovirus; HSV, herpes
simplex virus; tk, thymidine kinase; UT, untranslated region.
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expresses a protein in which only 15 amino acids ofCREB are
fused to the GAL4 DNA-binding domain. Cotransfection of
this plasmid did not lead to cAMP induction ofthe substituted
c-fos promoter (lanes 11 and 12). To show that the effect of
the fusion proteins required a specific binding site in cis, we
cotransfected an active GAL4-CREB plasmid with a c-fos
promoter in which the CRE was substituted with sequences
that inactivated the site without creating a GAL4 binding site.
This promoter did not respond to cAMP (lanes 13 and 14). We
conclude that both CREB cDNAs encode cAMP-responsive
transcription factors that can act in trans through a heterol-
ogous DNA-binding domain. Under our experimental con-
ditions, we did not detect consistent differences in activity
between the two forms of CREB.
DISCUSSION
We report here on the isolation of two distinct cDNAs that
encode CREB proteins. Both proteins are active as DNA-
binding proteins in vitro and as cAMP-dependent and
-independent transcriptional activators in vivo. The proteins
are capable of forming homodimers and possibly het-
erodimers, suggesting that in vivo, there could be three
distinct forms of CREB-two homodimers and one het-
erodimer. The two cDNAs correspond to cDNAs previously
isolated separately from human placenta and rat brain (11,
12). Our results show that the difference between the original
CREB isolates is not due to tissue or species specificity. Both
mRNAs are widely expressed in human and rodent cells.
These mRNAs are most likely alternative splicing products of
the same primary transcript. Polymerase chain reaction anal-
ysis of human placental DNA showed that there is a small
intron (:500 bp) located precisely at the 5' end of the insert
region in CREB genomic DNA (L.A.B., unpublished data).
Using a different experimental strategy, Gonzalez and
Montminy (13) have recently shown that the rat homolog of
CREB-B can augment induction of a CRE-containing pro-
moter by cotransfected PKA catalytic subunit in murine F9
embryonal carcinoma cells. This transcriptional activity is
dependent on an intact PKA phosphorylation site in CREB,
strongly suggesting that PKA directly regulates CREB func-
tion by phosphorylation in vivo. This activation could reflect
changes in either CREB DNA-binding or transcriptional
activity. Our experiments show that both forms ofCREB can
confer cAMP-regulated transcriptional activation to a heter-
ologous DNA-binding domain. Thus, increased concentra-
tions of cAMP, presumably acting through PKA, must influ-
ence the transcriptional stimulatory properties of CREB.
After this manuscript was submitted, Yamamoto et al. (21)
reported characterization ofthe rat homologues oftwo CREB
isoforms described here. In contrast to our results, they
observed a large difference in the transcriptional activities of
the two proteins in vivo. The discrepancy probably reflects
the rather significant differences in the assay systems used.
One possible explanation is that, as we discuss below, the
two proteins could respond differentially to an intracellular
signal expressed at different levels in F9 and BALB/c 3T3
cells; for example F9 cells could contain high levels of a
CREB-B-specific protein kinase absent from fibroblasts.
Another potential explanation stems from the relative con-
centrations of endogenous and exogenous CREB proteins in
the transfected cells. If the concentration of exogenous
CREB is low, it may form dimers predominantly with en-
dogenous proteins, distorting measurement of the activity
intrinsic to the protein encoded by the transfected cDNA.
Our GAL4-CREB fusion proteins, like intact CREB, could
also act in part by recruiting endogenous CREB via their free
leucine zippers. However, mutation of the serine residue
phosphorylated by PKA substantially reduces the activity of
the GAL4-CREB proteins in vivo (L.A.B., unpublished
data), so most of the activity we are measuring must be
intrinsic to the introduced proteins.
What is the functional significance of the two forms of
CREB? Sequences related to the CRE are implicated in
response to other stimuli, including phorbol esters, calcium,
and viral trans-activators (see, for example, refs. 20, 22-24).
In the case of calcium, a direct role for CREB has been
proposed (24). Furthermore, cAMP has often been reported
to synergize with or antagonize other agents (see, for exam-
ple, refs. 22 and 25). Thus, the 14-amino acid peptide found
in CREB-B could mediate response to other stimuli. The
presence in this peptide ofthree serines and a threonine raises
the possibility that this region is a target for cellular protein
kinases. Phosphorylation of CREB-B at distinct sites by
different protein kinases could form the basis for synergistic
activation with cAMP or could provide a site through which
stimulation by PKA phosphorylation is counteracted by
other signals. Thus, CREB proteins could serve as a molec-
ular focus for "crosstalk" often observed among signal
transduction pathways, integrating signaling information at
the level of gene transcription.
We thank G. Graham for assistance; M. Tanaka, C. Nicolet, M.
Steinhelper, L. Field, and J. Skowronski for materials; and K.
Riabowol, N. Hernandez, and T. Grodzicker for comments on the
manuscript. This work was supported by Public Health Service
Grants CA45642, CA46370, and A127270.
1. Edelman, A. M., Blumenthal, D. K. & Krebs, E. G. (1987) Annu.
Rev. Biochem. 56, 576-613.
2. Montminy, M. R., Sevarino, K. A., Wagner, J. A., Mandel, G. &
Goodman, R. H. (1986) Proc. Natl. Acad. Sci. USA 83, 6682-6686.
3. Mellon, P. L., Clegg, C. H., Correll, L. A. & McKnight, G. S.
(1989) Proc. Natl. Acad. Sci. USA 86, 4887-4891.
4. Riabowol, K. T., Fink, J. S., Gilman, M. Z., Walsh, D. A., Good-
man, R. H. & Feramisco, J. R. (1988) Nature (London) 336, 83-86.
5. Grove, J. R., Price, D. J., Goodman, H. M. & Avruch, J. (1987)
Science 238, 530-533.
6. Roesler, W. J., Vandenbark, G. R. & Hanson, R. W. (1988) J. Biol.
Chem. 263, 9063-9066.
7. Montminy, M. R. & Bilezikjian, L. M. (1987) Nature (London) 328,
175-178.
8. Yamamoto, K. K., Gonzalez, G. A., Biggs, W. H., III, & Mont-
miny, M. R. (1988) Nature (London) 334, 494-499.
9. Hai, T., Liu, F., Coukos, W. J. & Green, M. R. (1989) Genes Dev.
3, 2083-2090.
10. Maekawa, T., Sakura, H., Kanei-Ishii, C., Sudo, T., Yoshimura, T.,
Fujisawa, J., Yoshida, M. & Ishii, S. (1989) EMBO J. 8, 2023-2028.
11. Hoeffler, J. P., Meyer, T. E., Yun, Y., Jameson, J. L. & Habener,
J. F. (1988) Science 242, 1430-1433.
12. Gonzalez, G. A., Yamamoto, K. K., Fischer, W. H., Karr, D.,
Menzel, P., Biggs, W., III, Vale, W. W. & Montminy, M. R. (1989)
Nature (London) 337, 751-752.
13. Gonzalez, G. A. & Montminy, M. R. (1989) Cell 59, 675-680.
14. Littman, D. R., Thomas, Y., Maddox, P. J., Chess, L. & Axel, R.
(1985) Cell 40, 237-246.
15. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. USA 82, 488-492.
16. Berkowitz, L. A., Riabowol, K. T. & Gilman, M. Z. (1989) Mol.
Cell. Biol. 9, 4272-4281.
17. Webster, N., Jin, J. R., Green, S., Hollis, M. & Chambon, P. (1988)
Cell 52, 169-178.
18. Ma, J. & Ptashne, M. (1987) Cell 51, 113-119.
19. Johnson, P. F. & McKnight, S. L. (1989) Annu. Rev. Biochem. 58,
799-839.
20. Nakamura, M., Niki, M., Ohtani, K. & Sugamura, K. (1989)
Nucleic Acids Res. 17, 5207-5221.
21. Yamamoto, K. K., Gonzalez, G. A., Menzel, P., Rivier, J. &
Montminy, M. R. (1990) Cell 60, 611-617.
22. Comb, M., Birnberg, N. C., Seasholtz, A., Herbert, E. & Good-
man, H. M. (1986) Nature (London) 323, 353-356.
23. Hardy, S. & Shenk, T. (1988) Proc. Natl. Acad. Sci. USA 85,
4171-4175.
24. Sheng, M., McFadden, G. & Greenberg, M. E. (1990) Neuron 4,
571-582.
25. Deutsch, P. J., Hoeffler, J. P., Jameson, L. J. & Habener, J. F.
(1988) Proc. Nat!. Acad. Sci. USA 85, 7922-7926.
26. Dwarki, V. J., Montminy, M. & Verma, I. M. (1990) EMBO J. 9,
225-232.
Proc. Natl. Acad. Sci. USA 87 (1990)
